Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 124 (1) , 92-97
- https://doi.org/10.1016/j.ygyno.2011.09.034
Abstract
No abstract availableKeywords
Funding Information
- Samsung Biomedical Research Institute
This publication has 31 references indexed in Scilit:
- Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling DanesEuropean Journal Of Cancer, 2011
- Prime time for monocytesNature Reviews Immunology, 2010
- Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell AreasCell, 2010
- Squamous Carcinoma Cells Influence Monocyte Phenotype and Suppress Lipopolysaccharide-Induced TNF-alpha in MonocytesInflammation, 2010
- Asian society of gynecologic oncology workshop 2010Journal of Gynecologic Oncology, 2010
- Cancer Immunotherapy by Dendritic CellsImmunity, 2008
- The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literatureCritical Reviews in Oncology/Hematology, 2008
- T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligandNature, 2005
- Preoperative Serum Squamous Cell Carcinoma Antigen Levels in Clinical Decision Making for Patients With Early-Stage Cervical CancerJournal of Clinical Oncology, 2005
- Factors Regulating SCC Antigen Expression in Squamous Cell Carcinoma of the Uterine CervixTumor Biology, 1998